Literature DB >> 2838479

Initiation of adenovirus DNA replication. I. Mechanism of action of a host protein required for replication of adenovirus DNA templates devoid of the terminal protein.

M K Kenny1, L A Balogh, J Hurwitz.   

Abstract

The in vitro replication of adenovirus (Ad) DNA covalently attached to the 55-kDa terminal protein requires at least five proteins including the 80-kDa preterminal protein, the Ad DNA polymerase, the Ad DNA binding protein, nuclear factor I, and topoisomerase I. The replication of Ad DNA templates devoid of the terminal protein requires an additional protein, designated factor pL, which has been purified from uninfected HeLa cell nuclei (Guggenheimer, R. A., Nagata, K., Kenny, M., and Hurwitz, J. (1984) J. Biol. Chem. 259, 7815-7825). Factor pL has been found to contain an intrinsic 5'----3' exonuclease activity. When Ad DNA templates lacking the terminal protein were pretreated with factor pL, the requirement for factor pL in the replication reaction was abolished. Synthetic partially duplex oligonucleotide templates containing Ad origin sequences were constructed in order to determine the structure of the DNA molecules that are active in the absence of factor pL. These experiments indicated that factor pL degrades the 5'-end of the nontemplate (displaced) strand of the Ad origin thereby creating a single-stranded region at the 3'-end of the template strand. Such DNAs are competent for initiation of Ad DNA replication in the absence of factor pL but remain dependent on nuclear factor 1.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838479

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase.

Authors:  D Hartigan-O'Connor; A Amalfitano; J S Chamberlain
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

Review 2.  Recognition mechanisms in the synthesis of animal virus DNA.

Authors:  R T Hay; W C Russell
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

3.  Identification of rad27 mutations that confer differential defects in mutation avoidance, repeat tract instability, and flap cleavage.

Authors:  Y Xie; Y Liu; J L Argueso; L A Henricksen; H I Kao; R A Bambara; E Alani
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

4.  Linker insertion mutations in the adenovirus preterminal protein that affect DNA replication activity in vivo and in vitro.

Authors:  J N Fredman; S C Pettit; M S Horwitz; J A Engler
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

5.  DNA binding properties of the adenovirus DNA replication priming protein pTP.

Authors:  R N de Jong; L A T Meijer; P C van der Vliet
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

6.  Characterization of a replication-incompetent adenovirus type 5 mutant deleted for the preterminal protein gene.

Authors:  J Schaack; X Guo; S J Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

7.  Deletion of the E4 region of the genome produces adenovirus DNA concatemers.

Authors:  M D Weiden; H S Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

8.  The rad18 gene of Schizosaccharomyces pombe defines a new subgroup of the SMC superfamily involved in DNA repair.

Authors:  A R Lehmann; M Walicka; D J Griffiths; J M Murray; F Z Watts; S McCready; A M Carr
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

9.  Identification of two distinct regions within the adenovirus minimal origin of replication that are required for adenovirus type 4 DNA replication in vitro.

Authors:  S M Temperley; C R Burrow; T J Kelly; R T Hay
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

10.  Analysis of the adenovirus type 5 terminal protein precursor and DNA polymerase by linker insertion mutagenesis.

Authors:  D J Roovers; F M van der Lee; J van der Wees; J S Sussenbach
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.